Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Japanese CRO Croee To Establish NPO To Accelerate Patient Enrollment Process

This article was originally published in PharmAsia News

Executive Summary

Japanese contract research organization Croee plans to establish a non-profit organization to help enroll more clinical trial participants in Japan. As a third-party organization, the NPO will manage the database and protect individual privacy, promote public awareness of clinical trials and conduct follow-up activities such as providing information on new drugs after market launch. In Japan, medical facilities conducting clinical trials for pharmaceutical companies will ask site management organizations to start looking for patients to enroll in clinical studies. Croee hopes the new NPO will establish the patient database beforehand and will introduce candidates for certain trials to SMOs and hospitals. Croee has signed contracts with 50 SMOs and 500 hospitals. (Click here for more - Japanese language

Latest Headlines
See All
UsernamePublicRestriction

Register

SC071849

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel